Recent news on Fluocinolone

Medicis Begins Shipping PERLANE to Physicians  -  May 21, 2007
Primenewswire (press release),0.05%, VANOS(TM) (fluocinonide) Cream, 0.1%, SYNALAR(R) (fluocinolone acetonide), and ZIANA(TM) (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel,

Medidur Trial Exceeds 500 Patient Mark In Phase 3 Trial Enrollment  -  Apr 24, 2007
eMaxHealth.com,Medidur, a tiny, injectable intravitreal insert, is being studied as a way to deliver a very low dose of fluocinolone acetonide, a corticosteroid,to the

Alimera Sciences' Medidur Trial Exceeds 500 Patient Mark in Phase ...  -  Apr 23, 2007
PharmaLive.com (press release),Medidur, a tiny, injectable intravitreal insert, is being studied as a way to deliver a very low dose of fluocinolone acetonide, a corticosteroid,

pSivida Signs $165 Million(US) Collaborative Research and ...  -  Apr 5, 2007
Nanotechwire.com,Medidur in combination with Fluocinolone Acetonide is in Phase III clinical trials in DME in collaboration with Alimera Sciences Inc.,

Pfizer spies pSivida's injectable eye treatment  -  Apr 4, 2007
DrugResearcher.com,The insert is being studied as a way of delivering fluocinolone acetonide (a corticosteroid) to treat diabetic macular edema (DME), and has been designed to

Medicis Declares Cash Dividend  -  Mar 14, 2007
Primenewswire (press release),0.05%, VANOS(TM) (fluocinonide) Cream, 0.1%, SYNALAR(R) (fluocinolone acetonide), and ZIANA(TM) (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel,

PSDV: Retisert(TM) Receives Product Bill Code for Medicare ...  -  Jan 29, 2007
Insurance News Net,RetisertTM is surgically placed into the back of the eye and releases the steroid, fluocinolone acetonide at a constant rate over a period of up to 30

pSivida announces A$11.5m (US$9m) placement  -  Feb 19, 2007
dBusinessNews Boston (press release),...failure of Medidur™ to release fluocinolone acetonide at the same rate as Retisert™; our inability to recruit patients for the Phase III Medidur™ for

Mergers, Acquisitions, etc.  -  Feb 16, 2007
OSN SuperSite (subscription),...which will finance the development of pSivida’s Medidur (fluocinolone acetonide) drug delivery system for treating diabetic macular edema, according to

Medicis to Present At Roth Capital Partners 19th Annual OC Conference  -  Feb 15, 2007
PharmaLive.com (press release),0.05%, VANOS(TM) (fluocinonide) Cream, 0.1%, SYNALAR(R) (fluocinolone acetonide), ZIANA(TM) (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel,

AGI Dermatics Presents Comparative Data of 4% Hydroquinone ...  -  Feb 5, 2007
PR Newswire (press release),...and patches treated with an equal amount of a cream containing 4% HQ, 0.01% fluocinolone acetonide, (a steroid) and 0.05% tretinoin, a retin-a (HA/F+T).

pSivida Completes US$2.9m Placement  -  Dec 20, 2006
Genetic Engineering News (press release),Medidur(TM) for the delivery of a steroid (fluocinolone acetonide) for the treatment of the chronic eye disease diabetic macular edema (DME).

Medicis to Present At JPMorgan 25th Annual Healthcare Conference  -  Jan 4, 2007
PharmaLive.com (press release),0.05%, VANOS(TM) (fluocinonide) Cream, 0.1%, SYNALAR(R) (fluocinolone acetonide), ZIANA(TM) (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel,

pSivida Enters Licensing Negotiations with Major Global Pharma for ...  -  Dec 27, 2006
dBusinessNews Boston (press release),...failure of Medidur™ to release fluocinolone acetonide at the same rate as Retisert™; our inability to recruit patients for the Phase III Medidur™ for

pSivida Enters Licensing Negotiations with Major Global Pharma for ...  -  Dec 26, 2006
PharmaLive.com (press release),...diabetic retinopathy severity score as Retisert(TM) for DME; failure of Medidur(TM) to release fluocinolone acetonide at the same rate as Retisert(TM);

Alimera Sciences and Bausch & Lomb Announce Transaction for Alaway ...  -  Dec 20, 2006
dBusinessNews Atlanta (press release),2005 to study diabetic macular edema (DME) patients treated using Medidur™ with fluocinolone acetonide, the company’s pharmacologic treatment for DME.

pSivida Enters Licensing Negotiations with Major Global Pharma for ...  -  26 Dec 2006
PharmaLive.com (press release),...diabetic retinopathy severity score as Retisert(TM) for DME; failure of Medidur(TM) to release fluocinolone acetonide at the same rate as Retisert(TM);

Alimera Sciences and Bausch & Lomb Announce Transaction for Alaway ...  -  Dec 20, 2006
dBusinessNews Atlanta (press release),2005 to study diabetic macular edema (DME) patients treated using Medidur™ with fluocinolone acetonide, the company’s pharmacologic treatment for DME.

Medicis Declares Cash Dividend  -  Dec 14, 2006
Primenewswire (press release),0.05%, VANOS(TM) (fluocinonide) Cream, 0.1%, SYNALAR(R) (fluocinolone acetonide), ZIANA(TM) (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel,

Alimera Sciences Receives FDA Approval to Market Alaway(TM) OTC ...  -  Dec 5, 2006
CNW Telbec (Communiqués de presse),...with fluocinolone acetonide, the company's pharmacologic treatment for DME. http://www.alimerasciences.com For further information: Lisa Gibson Lake,

Alimera Sciences Receives FDA Approval to Market Alaway(TM) OTC ...  -  Dec 5, 2006
PR Newswire (press release),...edema (DME) patients treated using Medidur(TM) with fluocinolone acetonide, the company's pharmacologic treatment for DME. http://www.alimerasciences.com.

Alimera Sciences Completes Second Tranche of Series B Financing ...  -  Nov 27, 2006
CNW Telbec (Communiqués de presse),...and in October 2005 initiated a Phase III clinical trial to study diabetic macular edema (DME) patients treated using Medidur(TM) with fluocinolone

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional